Abstract
Annual influenza vaccination is recommended for patients with rheumatoid arthritis (RA), but coverage is suboptimal. We assessed the impact of an implementation strategy in enhancing vaccination uptake in RA. We evaluated a multimodal implementation strategy at rheumatology clinics that included 3 approaches: patient recalls, a nurse providing vaccines, and physician reminders. We compared patient-reported vaccination rates after implementation with those reported before the implementation strategy in a nonequivalent control group. In multivariate analyses, we assessed factors potentially associated with influenza vaccine uptake. One hundred and sixteen RA patients were vaccinated during the intervention. The influenza vaccination rate in RA increased from 48.5% (65/136) before implementation to 62.6% (67/107) after implementation (difference of 14.1, 95% CI 1.5, 26.1). In multivariate analyses, older age, biologics use, and physician recommendation for vaccination were associated with influenza vaccine uptake. A multimodal intervention was associated with increased influenza vaccine coverage among RA patients. Older patients and those on biologics were more likely to be immunized against influenza. Physician’s recommendations are important to promote vaccine coverage.
Key Points • Despite current recommendations, influenza vaccine uptake among rheumatoid arthritis (RA) patients is suboptimal. • A multimodal implementation strategy facilitating access to influenza vaccine and raising awareness through vaccination reminders improved immunization uptake in RA. • Physicians play a key role in promoting annual seasonal influenza vaccination. • The reasons for vaccine hesitancy in RA should be addressed to reach a vaccination target of 80% required to reduce the burden of this preventable infection. |
This is a preview of subscription content, log in via an institution to check access.
Data availability
Data is available from the corresponding author upon reasonable request.
References
Chow EJ, Doyle JD, Uyeki TM (2019) Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care 23(1):214. https://doi.org/10.1186/s13054-019-2491-9
Somes MP, Turner RM, Dwyer LJ, Newall AT (2018) Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: a systematic review and meta-analysis. Vaccine 36(23):3199–3207. https://doi.org/10.1016/j.vaccine.2018.04.063
World Health Organization. Influenza (Seasonal) https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Last access: June 21,2020
Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS, Global Seasonal Influenza-associated Mortality Collaborator N (2018) Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391(10127):1285–1300. https://doi.org/10.1016/S0140-6736(17)33293-2
Ng C, Ye L, Noorduyn SG, Hux M, Thommes E, Goeree R, Ambrose A, Andrew MK, Hatchette T, Boivin G, Bowie W, ElSherif M, Green K, Johnstone J, Katz K, Leblanc J, Loeb M, MacKinnon-Cameron D, McCarthy A, McElhaney J, McGeer A, Poirier A, Powis J, Richardson D, Sharma R, Semret M, Smith S, Smyth D, Stiver G, Trottier S, Valiquette L, Webster D, McNeil SA, Serious Outcomes Surveillance Network of the Canadian Immunization Research Network I, Toronto Invasive Bacterial Diseases Network I (2018) Resource utilization and cost of influenza requiring hospitalization in Canadian adults: a study from the serious outcomes surveillance network of the Canadian Immunization Research Network. Influenza Other Respir Viruses 12(2):232–240. https://doi.org/10.1111/irv.12521
Blumentals WA, Arreglado A, Napalkov P, Toovey S (2012) Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord 13:158. https://doi.org/10.1186/1471-2474-13-158
Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE (2002) Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 46(9):2287–2293. https://doi.org/10.1002/art.10524
Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A (2020) Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/keaa078
Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewe RB, Molto A, Muller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79(1):39–52. https://doi.org/10.1136/annrheumdis-2019-215882
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, Vaysbrot E, McNaughton C, Osani M, Shmerling RH, Curtis JR, Furst DE, Parks D, Kavanaugh A, O'Dell J, King C, Leong A, Matteson EL, Schousboe JT, Drevlow B, Ginsberg S, Grober J, St Clair EW, Tindall E, Miller AS, McAlindon T (2016) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 68(1):1–26. https://doi.org/10.1002/art.39480
Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O (2008) Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 67(7):1047. https://doi.org/10.1136/ard.2007.081703
Qendro T, de la Torre ML, Panopalis P, Hazel E, Ward BJ, Colmegna I, Hudson M (2020) Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care. J Rheumatol 47(5):770–778. https://doi.org/10.3899/jrheum.181376
Public Health Agency of Canada. Vaccination coverage goals and vaccine preventable disease reduction targets by 2025. https://www.canada.ca/en/public-health/services/immunization-vaccine-priorities/national-immunization-strategy/vaccination-coverage-goals-vaccine-preventable-diseases-reduction-targets-2025.html. Last access: May 20th, 2020
Thomas RE, Lorenzetti DL (2018) Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev 5:CD005188. https://doi.org/10.1002/14651858.CD005188.pub4
Jacobson Vann JC, Jacobson RM, Coyne-Beasley T, Asafu-Adjei JK, Szilagyi PG (2018) Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev 1:CD003941. https://doi.org/10.1002/14651858.CD003941.pub3
Acknowledgments
We thank Dr. Angeles Lopez-Olivo (MD Anderson Cancer Center) for providing methodological advice.
Funding
This work was supported by the Canadian Initiative for Outcomes in Rheumatology cAre (CIORA), the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) and the MUHC Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Ethical approval
This study was approved by the Ethics Committee of the McGill University Health Center (MUHC; protocol number 14–386 GEN).
Code availability
Not applicable
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 98 kb)
Rights and permissions
About this article
Cite this article
Valerio, V., Bazan, M.C., Wang, M. et al. A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritis. Clin Rheumatol 40, 575–579 (2021). https://doi.org/10.1007/s10067-020-05435-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-020-05435-3